Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Spok Holdings, Inc.NASDAQ: SPOK

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $8.72M rose 20.9% year over year, ahead of the -64.5% change in trailing-twelve-month cost of revenue. Over 3 fiscal years it compounded at -20.7% a year.

Context

  • Cost of revenue amounted to 21.2% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +20.9% holds above the trailing-twelve-month pace of -64.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.72M+250.5% QoQ
Last fiscal yearDec 2025
$29.57M+4.0% YoY
LTMMar 2026
$17.62M-64.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.9%——
1 year+4.0%——
3-year CAGR-20.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
29.57M USD
Year-over-year change
+4.0%
4-year CAGR
-20.0%

Cost of Revenue vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -64.5% is the lowest of 11, against a peer median of +10.4%.
  • Cost of revenue amounts to 12.9% of revenue for SPOK, versus a peer median of 44.9%.
SPOK Competitors
Cost of Revenue for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGCCanopy Growth CorporationLTM Mar 2026CA$234.68M CAD+23.9%-0.9%75.1%
TBRGTruBridge, Inc.LTM Mar 2026$168.68M USD+1.4%-0.7%48.8%
VMDViemed Healthcare, Inc.LTM Mar 2026$122.3M USD+27.2%+28.5%42.7%
CERSCerus CorporationLTM Mar 2026$101.8M USD+25.0%+8.5%45.7%
DHDefinitive Healthcare Corp.LTM Mar 2026$65.42M USD+14.6%+11.0%27.5%
NRCNational Research CorporationLTM Mar 2026$61.21M USD+6.1%+1.7%44.2%
SLPSimulations Plus, Inc.LTM Feb 2026$30.63M USD-12.8%+44.9%38.0%
MASS908 Devices Inc.LTM Mar 2026$29.48M USD+5.6%+12.2%51.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$26.56M USD+23.9%+21.8%32.7%
SENSSenseonics Holdings, Inc.LTM Mar 2026$19.51M USD-11.2%+12.6%47.9%
SPOKSpok Holdings, Inc.LTM Mar 2026$17.62M USD-64.5%-20.7%12.9%
Peer median (excluding SPOK) —+10.4%+11.6%44.9%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue142.15M134.53M139.03M137.65M139.71M
Cost of Revenue72.27M59.25M57.16M28.43M29.57M
Gross Profit69.89M75.28M81.87M109.22M110.14M
Gross Margin49.2%56.0%58.9%79.3%78.8%
Research & Development17.92M13.63M10.55M11.55M12.09M
Selling, General & Admin64.02M54.09M49.52M49.15M50.87M
Operating Expenses81.94M67.72M60.07M90.26M90.43M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
EBITDA(16.89M)4.57M26.82M24.22M24.87M
EBITDA Margin-11.9%3.4%19.3%17.6%17.8%
Operating Income(12.06M)7.57M21.8M18.97M19.71M
Operating Margin-8.5%5.6%15.7%13.8%14.1%
Interest Income320K592K1.1M1.15M820K
Interest Expense00000
Other Income / Expenses(15.28M)(6.57M)524K1.07M1.73M
Income Before Tax(27.33M)997K22.33M20.03M21.44M
Pre-Tax Margin-19.2%0.7%16.1%14.6%15.3%
Income Tax Expense(5.15M)(20.86M)6.66M5.07M5.56M
Net Income(22.18M)21.86M15.67M14.97M15.88M
Net Margin-15.6%16.2%11.3%10.9%11.4%
EPS (Basic)(1.14)1.110.790.740.77
EPS (Diluted)(1.14)1.090.770.730.75
Weighted Avg Shares19.4M19.67M19.95M20.24M20.61M
Weighted Avg Shares (Diluted)19.4M19.99M20.34M20.57M21.07M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.